A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation
NCT05918042
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Sponsor
AstraZeneca